Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
Arthritis Rheum. 2005 Jan;52(1):27-35. doi: 10.1002/art.20712.
Arthritis Rheum. 2005.
PMID: 15641102
Clinical Trial.